Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC

This article was originally published in The Tan Sheet

Executive Summary

Domestic comparable corporate store sales increased 8.1% for the fourth quarter, but decreased 1.5% for the full year, the supplement retailer announces Jan. 12. For franchise stores, sales increased 1.5% in the fourth quarter and decreased 4.8% for the full year. The company's comparable store sales "improved each successive quarter in 2005, finishing the year signficantly ahead of first quarter results," GNC states, attributing lower sales in early 2005 to "negative trends in the diet category." The firm is "very pleased with our progress in rebuilding our business in 2004"...

You may also be interested in...



Slipping Diet Market Reduces GNC Full-Year Sales

Continued decreases in the diet category were offset by gains in other product groups, resulting in a 2% decline in GNC's 2005 consolidated revenues, the company reported during a fourth-quarter and year-end earnings call March 2

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.

Simplified Clinical Trial Transparency Rules To Go Live In The EU In June

A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099004

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel